Stuart Naylor Biography and Net Worth

Insider of MeiraGTx

Dr. Stuart Naylor has served as our Chief Development Officer since April 2015. From April 2015 to April 2016, Dr. Naylor was Chief Executive Officer of Athena Vision, a biotechnology company. From June 2013 to April 2015, Dr. Naylor served as managing director of Coltivare Ltd., a healthcare consulting company. From 2008 to 2013, Dr. Naylor was Executive Director and Chief Scientific Officer of Oxford BioMedica plc, a gene therapy company. Prior to joining Oxford BioMedica, Dr. Naylor focused on translational cancer research at the Institute of Cancer Research. Dr. Naylor has a B.S.C. in microbiology and virology from the University of Warwick, a M.S. in Immunology from Kings College London, and a Ph.D. from the Imperial Cancer Research Fund laboratory studying ovarian cancer and cytokine biology.

What is Stuart Naylor's net worth?: The estimated net worth of Stuart Naylor is at least $2.81 million as of July 20th, 2021. Dr. Naylor owns 414,017 shares of MeiraGTx stock worth more than $2,807,035 as of March 31st. This net worth evaluation does not reflect any other investments that Dr. Naylor may own. Additionally, Dr. Naylor receives a salary of $1,060,000.00 as Insider at MeiraGTx. Learn More about Stuart Naylor's net worth.
How old is Stuart Naylor?: Dr. Naylor is currently 61 years old. There are 4 older executives and no younger executives at MeiraGTx. Learn More on Stuart Naylor's age.
What is Stuart Naylor's salary?: As the Insider of MeiraGTx Holdings plc, Dr. Naylor earns $1,060,000.00 per year. There are 3 executives that earn more than Dr. Naylor. The highest earning executive at MeiraGTx is Dr. Alexandria Forbes Ph.D., CEO, President & Director, who commands a salary of $2,890,000.00 per year. Learn More on Stuart Naylor's salary.
How do I contact Stuart Naylor?: The corporate mailing address for Dr. Naylor and other MeiraGTx executives is 450 East 29thStreet 14thFloor, NEW YORK NY, 10016. MeiraGTx can also be reached via phone at (646) 860-7985 and via email at investors@meiragtx.com. Learn More on Stuart Naylor's contact information.
Has Stuart Naylor been buying or selling shares of MeiraGTx?: Stuart Naylor has not been actively trading shares of MeiraGTx in the last ninety days. Most recently, Stuart Naylor sold 12,000 shares of the business's stock in a transaction on Monday, October 18th. The shares were sold at an average price of $17.95, for a transaction totalling $215,400.00. Learn More on Stuart Naylor's trading history.
Who are MeiraGTx's active insiders?: MeiraGTx's insider roster includes Alexandria Forbes (CEO), Richard Giroux (CFO), and Stuart Naylor (Insider). Learn More on MeiraGTx's active insiders.
Are insiders buying or selling shares of MeiraGTx?: During the last twelve months, MeiraGTx insiders bought shares 1 times. They purchased a total of 1,250,000 shares worth more than $5,000,000.00. During the last twelve months, insiders at the sold shares 2 times. They sold a total of 59,839 shares worth more than $382,838.33. The most recent insider tranaction occured on January, 21st when CFO Richard Giroux sold 24,000 shares worth more than $150,960.00. Insiders at MeiraGTx own 8.4% of the company. Learn More about insider trades at MeiraGTx.
Information on this page was last updated on 1/21/2025.

Stuart Naylor Insider Trading History at MeiraGTx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/18/2021	Sell	12,000	$17.95	$215,400.00
7/20/2021	Sell	9,390	$15.06	$141,413.40	414,017
7/13/2021	Sell	2,610	$15.04	$39,254.40	423,407
6/7/2021	Sell	1,042	$15.02	$15,650.84	431,057
4/30/2021	Sell	5,918	$15.10	$89,361.80	434,245
4/28/2021	Sell	3,772	$15.14	$57,108.08	434,245
1/4/2021	Sell	6,000	$15.40	$92,400.00	444,017
11/9/2020	Sell	8,794	$15.02	$132,085.88	455,380
11/5/2020	Sell	8,282	$15.02	$124,395.64	455,380
10/5/2020	Sell	301	$15.00	$4,515.00	463,662
7/20/2020	Sell	2,356	$15.00	$35,340.00	471,661
4/20/2020	Sell	696	$15.00	$10,440.00	485,321

Stuart Naylor Buying and Selling Activity at MeiraGTx

MeiraGTx Company Overview

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.

Today's Range

Now: $6.78

$6.63

$7.17

50 Day Range

MA: $6.84

$6.04

$8.25

2 Week Range

Now: $6.78

$3.85

$8.75

Volume

1,030,813 shs

Average Volume

286,946 shs

Market Capitalization

$534.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Stuart Naylor Biography and Net Worth

What is Stuart Naylor's net worth?

How old is Stuart Naylor?

What is Stuart Naylor's salary?

How do I contact Stuart Naylor?

Has Stuart Naylor been buying or selling shares of MeiraGTx?

Who are MeiraGTx's active insiders?

Are insiders buying or selling shares of MeiraGTx?